ASCEND BY NTHRYS
Research Abroad Products

Epigenomics Project Topics

Browse all focused areas across all project categories under this field.

Showing 193–200 of 200 project topics
Chromatin Accessibility Analysis Engine for Therapeutic Development
A proprietary analytics engine that measures chromatin accessibility using ATAC-seq and DNase-seq data to identify regulatory elements and transcription factor binding sites. This accelerates target identification for epigenetic therapies and increases funding opportunities through validated therapeutic mechanisms.
Epigenomics Consulting & Advisory Services Click to view more details →
Non-coding RNA Expression Intelligence Platform Commercial License
A licensed SaaS platform that detects and quantifies long non-coding RNA and microRNA expression patterns to predict disease progression and drug response. Pharmaceutical companies integrate this into their biomarker discovery pipelines to support regulatory submissions and expand market exclusivity windows.
Epigenomics Consulting & Advisory Services Click to view more details →
Epigenetic Aging Clock Development and Commercialization Service
A managed service that develops proprietary epigenetic aging clocks using machine learning on methylation data to assess biological age and longevity risk. Wellness companies and insurers monetize these clocks through premium personalization products and risk-stratified pricing models.
Epigenomics Consulting & Advisory Services Click to view more details →
ChIP-seq Data Integration and Interpretation SaaS
A cloud platform that processes, normalizes, and interprets ChIP-seq datasets to map protein-DNA interactions and predict transcriptional regulatory networks. Research institutions and biopharma companies reduce analysis turnaround time from weeks to hours and generate publication-quality results at scale.
Epigenomics Consulting & Advisory Services Click to view more details →
Personalized Epigenetic Therapy Response Prediction Engine
A machine learning platform that predicts patient response to HDAC inhibitors, DNA methyltransferase inhibitors, and other epigenetic drugs using multi-omics epigenetic data. This enables pharmaceutical companies to segment patient populations and optimize clinical trial design for accelerated regulatory approval.
Epigenomics Consulting & Advisory Services Click to view more details →
Environmental Exposure Epigenetic Biomarker Identification Consulting
A consulting service that identifies epigenetic signatures of environmental toxin exposure and develops biomarker assays for occupational health and environmental monitoring. Corporate clients use these biomarkers to support regulatory compliance, worker health programs, and liability risk assessment.
Epigenomics Consulting & Advisory Services Click to view more details →
Organoid and Tissue Culture Epigenetic Quality Control Platform
A specialized platform that monitors epigenetic drift and fidelity during organoid differentiation and culture expansion using rapid methylation profiling. Regenerative medicine companies ensure product consistency, reduce manufacturing failures, and achieve regulatory compliance for cell therapy manufacturing.
Epigenomics Consulting & Advisory Services Click to view more details →
Cancer Subtype Classification Engine Using Epigenomic Signatures
An AI-powered diagnostic tool that reclassifies cancer tumors into molecularly distinct subtypes using epigenomic data to guide treatment selection and prognosis prediction. Oncology centers and hospital networks improve treatment outcomes and generate reimbursable diagnostic revenue through precision cancer profiling services.
Epigenomics Consulting & Advisory Services Click to view more details →